Ahotupa M, Mäntylä E
Mol Pharmacol. 1983 Nov;24(3):464-70.
C57BL/6J (C57) and DBA/JBOMf (DBA) mice were used to study the role of adipose tissue as a modifier of tissue distribution, biological effects, and elimination of a lipophilic foreign chemical, 2,4,5,2',4',5'-hexachlorobiphenyl (HCB). As an indication of biological potency of the model compound, the activities of hepatic drug-metabolizing enzymes were determined. DBA mice contained twice as much body fat as C57 mice. Since the highly lipophilic HCB was primarily sequestered by the adipose tissue, DBA mice required greater doses of HCB than did C57 mice to reach similar tissue levels of the chemical. Accordingly, greater HCB doses were required by DBA mice for elevation of drug-metabolizing enzyme activities. Phenobarbital elevated enzyme activities in a similar way in both mouse strains. When the dietary intake of DBA mice was restricted, the body fat content decreased from 15% to 5% of body weight during 1 week. In these animals the tissue accumulation of HCB and enzyme induction resembled the situation in C57 mice fed ad libitum. Highest elevations were seen in the activities of 7-ethoxycoumarin-O-deethylase and arylhydrocarbon hydroxylase (EC 1.14.14.2). In addition, the activity of epoxide hydrolase (EC 3.3.2.3) was increased, whereas glutathione S-transferase as well as UDP-glucuronosyltransferase (EC 2.4.1.17) activities remained unchanged. The abundant adipose tissue content played no role in the nonresponsiveness of DBA mice to 3-methylcholanthrene since, in contrast to C57 mice, no changes in enzyme activities were detected in DBA mice deprived of food, even after large doses of 3-methylcholanthrene. The adipose tissue content also affected the rate of elimination of HCB. DBA mice excreted smaller quantities of HCB than did C57 mice after equal doses. When, however, fasted DBA mice received HCB, they excreted it at rates similar to those of C57 mice fed ad libitum. In C57 mice, concomitant to the elevation of monooxygenase activities, there was an increase in the rate of excretion of HCB. No such elevation could be seen after a dose that was too small to elevate enzyme activities.
采用C57BL/6J(C57)和DBA/JBOMf(DBA)小鼠研究脂肪组织作为亲脂性外来化学物质2,4,5,2',4',5'-六氯联苯(HCB)组织分布、生物学效应及消除的调节剂的作用。作为模型化合物生物学活性的指标,测定了肝脏药物代谢酶的活性。DBA小鼠的体脂含量是C57小鼠的两倍。由于高度亲脂性的HCB主要被脂肪组织所隔离,与C57小鼠相比,DBA小鼠需要更高剂量的HCB才能达到相似的组织化学水平。因此,DBA小鼠需要更高剂量的HCB来提高药物代谢酶的活性。苯巴比妥在两种小鼠品系中以相似的方式提高酶活性。当限制DBA小鼠的饮食摄入时,在1周内其体脂含量从体重的15%降至5%。在这些动物中,HCB的组织蓄积和酶诱导与自由采食的C57小鼠相似。7-乙氧基香豆素-O-脱乙基酶和芳烃羟化酶(EC 1.14.14.2)的活性升高最为明显。此外,环氧水解酶(EC 3.3.2.3)的活性增加,而谷胱甘肽S-转移酶以及UDP-葡萄糖醛酸基转移酶(EC 2.4.1.17)的活性保持不变。丰富的脂肪组织含量对DBA小鼠对3-甲基胆蒽无反应性不起作用,因为与C57小鼠不同,即使给予大剂量的3-甲基胆蒽,剥夺食物的DBA小鼠的酶活性也未检测到变化。脂肪组织含量也影响HCB的消除速率。给予相同剂量后,DBA小鼠排出的HCB量比C57小鼠少。然而,禁食的DBA小鼠接受HCB后,其排出速率与自由采食的C57小鼠相似。在C57小鼠中,随着单加氧酶活性的升高,HCB的排泄速率也增加。给予太小而无法提高酶活性的剂量后,未观察到这种升高。